CSC Financial: AI4S is approaching the critical point of industrialization

CSC Securities research report states that currently, the AI pharmaceutical industry chain has evolved into a networked empowerment system centered on platforms and technology middle offices, with deep collaboration across upstream, midstream, and downstream, and is showing a development trend of compatible and parallel advancement of multiple business models. AI4S is moving from a competition in model capabilities to the critical point of industrialization, with a fourfold resonance of technology, industry, demand, and policy, and the value anchor is upgrading from model capabilities to scientific research productivity, data assets, and systematic biological design.